Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cephalon initiates testing of modafinil for excessive daytime sleepiness in sleep apnea sufferers

May 12, 1999

Paxil approved in two major markets for social anxiety disorder

May 12, 1999

Anesta enters partnership with Swedish Orphan for Actiq

May 12, 1999

Safe, dose-dependent MAO-B inhibition in healthy volunteers administered SL-34.0026

May 11, 1999

Potential anxiolytics/antidepressants under development at DuPont

May 11, 1999

Substituted indan derivatives with selective affinity for 5-HT1B receptors

May 11, 1999

Single-isomer valproic acid patented in Japan

May 10, 1999

Licensing opportunity from NIH: BChE inhibitors for Alzheimer's disease Rx, Dx

May 10, 1999

Amarillo's fibromyalgia trial expanded

May 10, 1999

Caspase inhibitor provides neuroprotection in rabbit model of bacterial meningitis

May 7, 1999

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026